Current through Reg. 49, No. 52; December 27, 2024
(a) The
permit holder shall participate in the central registry for the purpose of
sharing patient identifying information as requested by the department to
prevent multiple enrollment of patients in narcotic treatment programs
(NTPs).
(b) A narcotic drug shall
not be provided to a patient who is known to be currently enrolled in another
NTP except when the patient is a temporary transfer patient.
(c) The patient shall always report to the
same NTP unless prior approval is requested by the parent NTP's program
physician or program director for the patient to receive treatment as a
temporary transfer patient at another NTP. In any event, a patient may not be
authorized more than two weeks away from their home clinic without prior
approval from the State Methadone Authority (SMA).
(d) A central registry shall be established
by the department which shall maintain a record of the patient's identification
and the NTP to which each patient is enrolled. Information shall be maintained
in accordance with confidentiality requirements in the Code of Federal
Regulations, Title 42, Part 2, and Title 42, §8.12(g).
(e) Each NTP shall report to the central
registry specific information.
(1) The
following changes in patient status: new patient, readmitted to the same
clinic, admitted from another NTP as a permanent transfer patient, transferred
to another narcotic maintenance or detoxification program, deceased patient, or
discharged (terminated) from maintenance or detoxification treatment shall be
identified and reported to the central registry located at the department by
telephone, electronic mail, or facsimile on the day the action occurs and
written documentation must be submitted within a 24-hour period (or the next
state working day immediately following weekends or holidays).
(2) Each NTP's verbal and written report to
the central registry shall identify and provide the following information for
each patient:
(A) name, address, and
telephone number of the NTP, and approved narcotic drug permit
number;
(B) date action was taken
(MO-DA-YR);
(C) action taken
identified as:
(i) new patient, readmitted
patient (NP);
(ii) terminated
patient (TP);
(iii) permanent
transfer-in patient (TIP);
(iv)
permanent transfer-out patient (TOP); or
(v) deceased patient (DP); and
(D) patient identification as
follows:
(i) Upon admission, the patient must
be identified with a current Texas state driver's license, United States
passport, military identification card, or Texas state-issued identification
card containing a photograph of the patient or other identification approved by
the SMA. If a patient is not able or willing to furnish the required documents,
the program shall contact the SMA within 72 hours to access the Central
Registry to check for possible duplicate enrollment and to discuss acceptable,
alternate forms of identification. Photocopies of each of these documents must
be maintained in the patient's record. The program shall document in the
patient's file attempts to induce the patient to obtain state
identification.
(ii) An
identification number shall be constructed using the following code numbers for
the patient:
(I) color of eyes: Brown (1),
Blue (2), Green (3), Hazel (4), Gray (5), and Other (6);
(II) date of birth stated in number digits
with two digits for the month, day, and year (example: January 9,
1953--010953);
(III) gender: male
(1) and female (2); and
(IV) race:
White (1), Black (2), Hispanic (3), Asian (4), American Indian (5), and Other
(6).
(iii) An example of
a patient identification number in accordance with clause (ii) of this
subparagraph for a patient with blue eyes, date of birth--January 9, 1953,
male, and white is 201095311. Patients with the same identification code will
be assigned an alphabetical extension by the SMA (for example 201095311A,
201095311B, etc.).
